News Lupin Reports the P-III Study Completion of LUBT010 (Biosimilar, Lucentis) for Neovascular Age-related Macular Degeneration ByDipanshu DixitAugust 5, 20240Comments
News Celltrion’s Steqeyma (Biosimilar, Stelara) Receives the Health Canada’s Approval to Treat Various Chronic Inflammatory Conditions ByDipanshu DixitAugust 1, 20240Comments
News Xbrane Biopharma Reclaims Rights of BIIB801 (Biosimilar, Cimzia) from Biogen ByDipanshu DixitAugust 1, 20240Comments
VIEWPOINTS Redefining Care: Gunjan Sharma from The US Oncology Network in Conversation with PharmaShotsBySaurabh ChaubeyJuly 31, 20240Comments
VIEWPOINTS Enhancing Capabilities: Tahi Ahmadi from Genmab in a Riveting Dialogue Exchange with PharmaShotsBySaurabh ChaubeyJuly 29, 20240Comments
News Astellas Reports the CHMP’s Positive Opinion of Zolbetuximab to Treat Gastric and Gastroesophageal Junction Cancer ByDipanshu DixitJuly 29, 20240Comments
News Novaliq’s Vevizye (Ciclosporin) gains the CHMP’s Positive Opinion to Prevent Moderate to Severe Dry Eye Disease (DED) ByDipanshu DixitJuly 29, 20240Comments
